デフォルト表紙
市場調査レポート
商品コード
1701107

バイオセンサーの市場規模、シェア、成長分析:タイプ別、製品別、技術別、コンポーネント別、用途別、地域別 - 産業予測 2025~2032年

Biosensors Market Size, Share, and Growth Analysis, By Type (Sensor Patch, Embedded Device), By Product (Wearable Biosensors, Non-Wearable Biosensors), By Technology, By Component, By Application, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
バイオセンサーの市場規模、シェア、成長分析:タイプ別、製品別、技術別、コンポーネント別、用途別、地域別 - 産業予測 2025~2032年
出版日: 2025年04月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオセンサー2023年の市場規模は302億7,000万米ドルで、2024年の327億2,000万米ドルから2032年には610億2,000万米ドルに成長し、予測期間(2025~2032年)のCAGRは8.1%で成長する見通しです。

バイオセンサー市場は、糖尿病や心血管問題などの慢性疾患の世界の増加により、著しい成長を遂げています。これらの分析装置は、細胞、組織、酵素が関与する生体反応を電気信号に変換し、環境モニタリング、食糧安全保障、生物医学研究を促進します。人口の増加は、病院や薬局における医療診断ツールの需要を高めています。さらに、バイオセンサーを搭載した診断機器の普及により、迅速かつ正確な疾病診断が可能になり、患者のケアも向上しています。先進的なバイオセンサ・プラットフォームを開発するために半導体企業と医療機器企業が提携する動向は、市場拡大をさらに加速させています。早期診断と個別化医療が重視されるようになるにつれ、バイオセンサー市場は継続的な開拓とイノベーションの態勢が整いつつあります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 技術の進歩
  • 規制情勢
  • 特許分析

バイオセンサー市場規模:タイプ別

  • 市場概要
  • センサーパッチ
  • 組み込みデバイス

バイオセンサー市場規模:製品別

  • 市場概要
  • ウェアラブルバイオセンサー
    • リストウェア
    • アイウェア
    • フットウェア
    • ネックウェア
    • ボディウェア
    • その他
  • 非ウェアラブルバイオセンサー

バイオセンサー市場規模:技術別

  • 市場概要
  • 電気化学バイオセンサー
    • アンペロメトリックセンサー
    • 電位差センサー
    • 導電率センサー
  • 光学バイオセンサー
    • SPR
    • 色彩測定バイオセンサー
    • 蛍光バイオセンサー
  • 圧電バイオセンサー
    • アコースティックバイオセンサー
    • マイクロカンチレバーバイオセンサー
  • サーマルバイオセンサー
  • ナノメカニカルバイオセンサー

バイオセンサー市場規模:コンポーネント別

  • 市場概要
  • バイオレセプター分子
  • 生物学的要素
  • トランスデューサー

バイオセンサー市場規模:用途別

  • 市場概要
  • ポック
    • 血糖モニタリング
    • 心臓マーカー
    • 感染症検出
    • 凝固モニタリング
    • 妊娠検査
    • 血液ガスおよび電解質検出
    • 腫瘍またはがんマーカーの検出
    • 尿検査
    • コレステロール検査
  • ホーム診断
    • 血糖モニタリング
    • 妊娠検査
    • コレステロール検査
  • 調査室
  • 環境モニタリング
  • 食品・飲料
  • バイオディフェンス

バイオセンサー市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022~2024年)

主要企業プロファイル

  • Abbott Laboratories(USA)
  • Roche Diagnostics(Switzerland)
  • Medtronic plc(Ireland)
  • Bio-Rad Laboratories, Inc.(USA)
  • DuPont(USA)
  • Biosensors International Group, Ltd.(Singapore)
  • Cytiva(UK)
  • Dexcom, Inc.(USA)
  • Lifescan IP Holdings, LLC(USA)
  • Masimo Corporation(USA)
  • Nova Biomedical(USA)
  • Universal Biosensors(Australia)
  • ACON Laboratories, Inc.(USA)
  • CARDEA BIO INC.(USA)
  • Conductive Technologies(USA)
  • EarlySense(Israel)
  • Innovative Sensor Technology IST AG(Switzerland)
  • LifeSignals(USA)
  • NeuroSky(USA)
  • SD Biosensor, INC.(South Korea)

結論と提言

目次
Product Code: SQMIG45J2077

Biosensors Market size was valued at USD 30.27 billion in 2023 and is poised to grow from USD 32.72 billion in 2024 to USD 61.02 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The biosensor market is witnessing significant growth due to rising chronic diseases like diabetes and cardiovascular issues globally. These analytical devices convert biological reactions involving cells, tissues, and enzymes into electrical signals, facilitating environmental monitoring, food security, and biomedical research. The increasing population has elevated the demand for medical diagnostic tools in hospitals and pharmacies. Furthermore, the proliferation of diagnostic devices featuring biosensors enables rapid and accurate disease diagnosis, enhancing patient care. The trend of collaborations between semiconductor and medical device companies to develop advanced biosensor platforms is further accelerating market expansion. As the emphasis on early diagnosis and personalized medicine grows, the biosensor market is poised for continued development and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biosensors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biosensors Market Segments Analysis

Global Biosensors Market is segmented by Type, Product, Technology, Component, Application and region. Based on Type, the market is segmented into Sensor Patch and Embedded Device. Based on Product, the market is segmented into Wearable Biosensors and Non-Wearable Biosensors. Based on Technology, the market is segmented into Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors and Nanomechanical Biosensors. Based on Component, the market is segmented into Bioreceptor Molecules, Biological Element and Transducer. Based on Application, the market is segmented into Poc, Home Diagnostics, Research Labs, Environmental Monitoring, Food & Beverages and Biodefense. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biosensors Market

The biosensors market is propelled by the increasing demand for point-of-care (POC) assays, particularly within the healthcare sector. These innovative devices facilitate quick, precise, and portable testing, which is crucial for tracking chronic illnesses, handling urgent health issues, and addressing public health crises. The effectiveness of POC testing has spurred its implementation across diverse environments, ranging from clinical facilities to home care settings, significantly contributing to the expansion of the biosensors market. This rising trend reflects a broader shift towards more accessible healthcare solutions that enhance patient outcomes and streamline medical responses.

Restraints in the Biosensors Market

A significant constraint in the biosensors market is the elevated cost linked to the development of sophisticated biosensors. The creation and production of highly sensitive and precise biosensors typically require costly materials and intricate manufacturing techniques. Such expenses can hinder widespread adoption, particularly in resource-constrained settings and developing regions, where affordability plays a crucial role in implementation. Consequently, these financial challenges may limit the accessibility of advanced biosensing technologies to a broader audience, impeding market growth and innovation in areas that could greatly benefit from these advancements in healthcare and diagnostics.

Market Trends of the Biosensors Market

The biosensors market is witnessing a significant trend driven by the rising deployment of devices for diabetes monitoring. As diabetes prevalence escalates globally, there is a growing demand for early diagnosis and continuous surveillance of the disease. Biosensors offer superior advantages, including accurate insulin estimation and cost-effectiveness, making them essential for effective management and treatment efficacy in diabetic patients. Traditional methods of insulin detection are often time-consuming and lack real-time monitoring capabilities, presenting an opportunity for biosensors to enhance patient care. This shift towards innovative, reliable, and quicker diagnostic solutions is propelling the biosensors market towards substantial growth in the healthcare sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape
  • Patent Analysis

Global Biosensors Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Sensor Patch
  • Embedded Device

Global Biosensors Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Wearable Biosensors
    • Wristwear
    • Eyewear
    • Footwear
    • Neckwear
    • Bodywear
    • Others
  • Non-Wearable Biosensors

Global Biosensors Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Electrochemical Biosensors
    • Amperometric Sensors
    • Potentiometric Sensors
    • Conductometric Sensors
  • Optical Biosensors
    • SPR
    • Colorimetric Biosensors
    • Fluorescence Biosensors
  • Piezoelectric Biosensors
    • Acoustic Biosensors
    • Microcantilever Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors

Global Biosensors Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Bioreceptor Molecules
  • Biological Element
  • Transducer

Global Biosensors Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Poc
    • Glucose Monitoring
    • Cardiac Marker
    • Infectious Disease Detection
    • Coagulation Monitoring
    • Pregnancy Testing
    • Blood Gas & Electrolyte Detection
    • Detection Of Tumor Or Cancer Marker
    • Urinalysis Testing
    • Cholesterol Testing
  • Home Diagnostics
    • Glucose Monitoring
    • Pregnancy Testing
    • Cholesterol Testing
  • Research Labs
  • Environmental Monitoring
  • Food & Beverages
  • Biodefense

Global Biosensors Market Size & CAGR (2025-2032)

  • North America (Type, Product, Technology, Component, Application)
    • US
    • Canada
  • Europe (Type, Product, Technology, Component, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Product, Technology, Component, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Product, Technology, Component, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Product, Technology, Component, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DuPont (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosensors International Group, Ltd. (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cytiva (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dexcom, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifescan IP Holdings, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Masimo Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nova Biomedical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Universal Biosensors (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ACON Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CARDEA BIO INC. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conductive Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EarlySense (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innovative Sensor Technology IST AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LifeSignals (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroSky (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SD Biosensor, INC. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations